Birdwatch Note
2024-04-10 00:31:16 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
CureusはIFが1.2で極めて低く査読も短く信頼できないとされる機関出版物トップ2の雑誌です https://en.wikipedia.org/wiki/Cureus この接種後の癌超過死亡もまず早期蔓延国では20年から生じている例が複数あり↓ https://www.mdpi.com/1660-4601/20/6/5156 https://pubmed.ncbi.nlm.nih.gov/37182218/ インフル流行に応じても生じ↓ https://www.jstage.jst.go.jp/article/jjh/63/1/63_1_5/_pdf この論文図でも↓ https://assets.cureus.com/uploads/figure/file/967567/lightbox_4c68a1f0eb0a11eeb1743f11e75c4a60-fig.1-Mortlity-Rates-All-cancers-yeary-and-monthly.png 感染研のがん超過死亡でも20年12月から既に超過死亡が見られてます https://exdeaths-japan.org/graph/weekly_cause また著者らは感染数を示して流行拡大より接種拡大の方が関連が高い様に見せかけてますが↓ https://assets.cureus.com/uploads/figure/file/967567/lightbox_4c68a1f0eb0a11eeb1743f11e75c4a60-fig.1-Mortlity-Rates-All-cancers-yeary-and-monthly.png 入院数を使うと全く逆で入院数が3→8波と拡大するにつれ癌の超過死亡が拡大した一方で接種は21年の方が高いのにがん超過死亡は22年の方が多いです↓ https://medicalfacts.info/infect.rb?c=Japan&from=2020-02-01&to=2022-12-25&hosp_patients=true&new_vaccinations_smoothed_per_million=true&excess_mortality=true&two=true&l=ja&i=false https://assets.cureus.com/uploads/figure/file/967567/lightbox_4c68a1f0eb0a11eeb1743f11e75c4a60-fig.1-Mortlity-Rates-All-cancers-yeary-and-monthly.png
Written by F4D2E4CA66E08B99BDDE8328BBF4C2313B853B3595C8AC38600E463328C72D9D
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1777847749867946474
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1777856840296284458
- noteId - 1777856840296284458
- participantId -
- noteAuthorParticipantId - F4D2E4CA66E08B99BDDE8328BBF4C2313B853B3595C8AC38600E463328C72D9D Participant Details
- createdAtMillis - 1712709076368
- tweetId - 1777847749867946474
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 1
- misleadingManipulatedMedia - 1
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 1
- misleadingUnverifiedClaimAsFact - 1
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- CureusはIFが1.2で極めて低く査読も短く信頼できないとされる機関出版物トップ2の雑誌です https://en.wikipedia.org/wiki/Cureus この接種後の癌超過死亡もまず早期蔓延国では20年から生じている例が複数あり↓ https://www.mdpi.com/1660-4601/20/6/5156 https://pubmed.ncbi.nlm.nih.gov/37182218/ インフル流行に応じても生じ↓ https://www.jstage.jst.go.jp/article/jjh/63/1/63_1_5/_pdf この論文図でも↓ https://assets.cureus.com/uploads/figure/file/967567/lightbox_4c68a1f0eb0a11eeb1743f11e75c4a60-fig.1-Mortlity-Rates-All-cancers-yeary-and-monthly.png 感染研のがん超過死亡でも20年12月から既に超過死亡が見られてます https://exdeaths-japan.org/graph/weekly_cause また著者らは感染数を示して流行拡大より接種拡大の方が関連が高い様に見せかけてますが↓ https://assets.cureus.com/uploads/figure/file/967567/lightbox_4c68a1f0eb0a11eeb1743f11e75c4a60-fig.1-Mortlity-Rates-All-cancers-yeary-and-monthly.png 入院数を使うと全く逆で入院数が3→8波と拡大するにつれ癌の超過死亡が拡大した一方で接種は21年の方が高いのにがん超過死亡は22年の方が多いです↓ https://medicalfacts.info/infect.rb?c=Japan&from=2020-02-01&to=2022-12-25&hosp_patients=true&new_vaccinations_smoothed_per_million=true&excess_mortality=true&two=true&l=ja&i=false https://assets.cureus.com/uploads/figure/file/967567/lightbox_4c68a1f0eb0a11eeb1743f11e75c4a60-fig.1-Mortlity-Rates-All-cancers-yeary-and-monthly.png
Note Status History
createdAt | timestampMillisOfFirstNonNMRStatus | firstNonNMRStatus | timestampMillisOfCurrentStatus | currentStatus | timestampMillisOfLatestNonNMRStatus | mostRecentNonNMRStatus | participantId |
2024-04-10 00:31:16 UTC (1712709076368) |
2024-04-10 07:44:00 UTC (1712735040380) |
CURRENTLY_RATED_HELPFUL | 2024-04-11 01:57:44 UTC (1712800664269) |
NEEDS_MORE_RATINGS | 2024-04-10 07:44:00 UTC (1712735040380) |
CURRENTLY_RATED_HELPFUL |
Note Ratings
rated at | rated by | |
2024-04-09 20:51:05 -0500 | Rating Details | |
2024-04-09 20:48:52 -0500 | Rating Details | |
2024-04-09 20:34:35 -0500 | Rating Details | |
2024-04-09 20:32:28 -0500 | Rating Details | |
2024-04-09 20:26:02 -0500 | Rating Details | |
2024-04-09 20:16:20 -0500 | Rating Details | |
2024-04-09 20:07:59 -0500 | Rating Details | |
2024-04-09 20:06:30 -0500 | Rating Details | |
2024-04-09 19:53:37 -0500 | Rating Details | |
2024-04-09 19:36:27 -0500 | Rating Details | |
2024-04-10 18:04:55 -0500 | Rating Details | |
2024-04-10 17:54:29 -0500 | Rating Details | |
2024-04-10 17:46:00 -0500 | Rating Details | |
2024-04-10 17:32:52 -0500 | Rating Details | |
2024-04-10 17:21:16 -0500 | Rating Details | |
2024-04-10 14:46:28 -0500 | Rating Details | |
2024-04-10 11:46:32 -0500 | Rating Details | |
2024-04-10 10:59:45 -0500 | Rating Details | |
2024-04-10 07:51:39 -0500 | Rating Details | |
2024-04-10 07:01:29 -0500 | Rating Details | |
2024-04-10 01:21:45 -0500 | Rating Details | |
2024-04-10 00:38:53 -0500 | Rating Details | |
2024-04-10 00:21:26 -0500 | Rating Details | |
2024-04-09 23:45:02 -0500 | Rating Details | |
2024-04-09 23:35:54 -0500 | Rating Details | |
2024-04-09 23:22:36 -0500 | Rating Details | |
2024-04-09 22:58:08 -0500 | Rating Details | |
2024-04-09 22:19:27 -0500 | Rating Details | |
2024-04-09 22:02:40 -0500 | Rating Details | |
2024-04-09 21:57:41 -0500 | Rating Details | |
2024-04-09 21:50:45 -0500 | Rating Details | |
2024-04-11 18:01:53 -0500 | Rating Details | |
2024-04-11 17:58:03 -0500 | Rating Details | |
2024-04-11 07:52:46 -0500 | Rating Details | |
2024-04-11 00:25:47 -0500 | Rating Details | |
2024-04-12 20:52:24 -0500 | Rating Details | |
2024-04-12 05:43:59 -0500 | Rating Details | |
2024-04-11 23:14:31 -0500 | Rating Details | |
2024-04-11 22:48:01 -0500 | Rating Details | |
2024-04-10 11:43:14 -0500 | Rating Details | |
2024-04-15 00:12:04 -0500 | Rating Details | |
2024-04-12 08:02:51 -0500 | Rating Details | |
2024-04-11 10:10:38 -0500 | Rating Details | |
2024-04-11 00:41:34 -0500 | Rating Details | |
2024-04-10 23:16:48 -0500 | Rating Details | |
2024-04-10 22:00:23 -0500 | Rating Details | |
2024-04-10 17:19:24 -0500 | Rating Details | |
2024-04-10 17:11:55 -0500 | Rating Details | |
2024-04-10 14:14:22 -0500 | Rating Details | |
2024-04-10 12:05:24 -0500 | Rating Details | |
2024-04-10 10:58:22 -0500 | Rating Details | |
2024-04-10 10:13:56 -0500 | Rating Details | |
2024-04-10 09:45:02 -0500 | Rating Details | |
2024-04-10 08:58:08 -0500 | Rating Details | |
2024-04-10 07:25:30 -0500 | Rating Details | |
2024-04-10 02:57:23 -0500 | Rating Details | |
2024-04-10 01:36:21 -0500 | Rating Details | |
2024-04-10 01:19:22 -0500 | Rating Details | |
2024-04-10 01:07:42 -0500 | Rating Details | |
2024-04-10 01:03:50 -0500 | Rating Details | |
2024-04-10 00:55:07 -0500 | Rating Details | |
2024-04-10 00:50:34 -0500 | Rating Details | |
2024-04-10 00:16:45 -0500 | Rating Details | |
2024-04-09 23:39:07 -0500 | Rating Details | |
2024-04-09 22:39:01 -0500 | Rating Details | |
2024-04-09 22:35:55 -0500 | Rating Details | |
2024-04-09 21:14:45 -0500 | Rating Details | |
2024-04-09 21:11:35 -0500 | Rating Details | |
2024-04-09 20:30:04 -0500 | Rating Details | |
2024-04-09 20:26:29 -0500 | Rating Details | |
2024-04-09 20:21:32 -0500 | Rating Details | |
2024-04-09 20:20:41 -0500 | Rating Details | |
2024-04-09 20:19:42 -0500 | Rating Details | |
2024-04-09 20:13:06 -0500 | Rating Details | |
2024-04-09 20:08:32 -0500 | Rating Details | |
2024-04-09 20:07:54 -0500 | Rating Details | |
2024-04-09 19:55:51 -0500 | Rating Details | |
2024-04-09 19:37:07 -0500 | Rating Details | |
2024-04-09 19:36:44 -0500 | Rating Details | |
2024-04-10 08:57:39 -0500 | Rating Details | |
2024-04-10 10:10:09 -0500 | Rating Details | |
2024-04-12 07:57:10 -0500 | Rating Details | |
2024-04-12 22:08:40 -0500 | Rating Details | |
2024-04-12 02:18:21 -0500 | Rating Details | |
2024-04-11 23:26:25 -0500 | Rating Details | |
2024-04-11 18:53:39 -0500 | Rating Details | |
2024-04-11 16:22:49 -0500 | Rating Details | |
2024-04-11 15:35:34 -0500 | Rating Details | |
2024-04-11 08:33:56 -0500 | Rating Details | |
2024-04-10 19:30:06 -0500 | Rating Details | |
2024-04-10 16:31:36 -0500 | Rating Details | |
2024-04-10 16:18:19 -0500 | Rating Details | |
2024-04-10 12:49:20 -0500 | Rating Details | |
2024-04-10 12:29:59 -0500 | Rating Details | |
2024-04-10 11:53:58 -0500 | Rating Details | |
2024-04-10 11:45:36 -0500 | Rating Details | |
2024-04-10 11:27:46 -0500 | Rating Details | |
2024-04-10 10:24:38 -0500 | Rating Details | |
2024-04-10 10:11:58 -0500 | Rating Details | |
2024-04-10 09:03:26 -0500 | Rating Details | |
2024-04-10 06:18:08 -0500 | Rating Details | |
2024-04-10 06:15:54 -0500 | Rating Details | |
2024-04-10 05:50:22 -0500 | Rating Details | |
2024-04-10 01:01:47 -0500 | Rating Details | |
2024-04-09 23:33:11 -0500 | Rating Details | |
2024-04-09 23:30:58 -0500 | Rating Details | |
2024-04-09 23:07:49 -0500 | Rating Details | |
2024-04-09 21:17:03 -0500 | Rating Details | |
2024-04-09 21:11:22 -0500 | Rating Details | |
2024-04-09 20:32:12 -0500 | Rating Details | |
2024-04-09 20:32:09 -0500 | Rating Details | |
2024-04-09 20:12:53 -0500 | Rating Details | |
2024-04-09 20:02:54 -0500 | Rating Details | |
2024-04-09 19:42:37 -0500 | Rating Details | |
2024-04-09 19:41:44 -0500 | Rating Details | |
2024-04-09 19:40:30 -0500 | Rating Details | |
2024-04-09 19:36:33 -0500 | Rating Details | |
2024-04-09 19:35:57 -0500 | Rating Details | |
2024-04-09 19:34:04 -0500 | Rating Details | |
2024-05-16 05:41:13 -0500 | Rating Details |